“Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.”, Hum Vaccin Immunother, vol. 8, no. 5, pp. 630-8, 2012.
, “Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis.”, Pediatr Transplant, vol. 6, no. 6, pp. 488-92, 2002.
, “Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.”, PLoS One, vol. 5, no. 1, p. e8816, 2010.
, “Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.”, PLoS One, vol. 5, no. 1, p. e8617, 2010.
, “Racial and center differences in hemodialysis adequacy in children treated at pediatric centers: a North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) report.”, J Am Soc Nephrol, vol. 15, no. 11, pp. 2923-32, 2004.
, “The role of APD in the management of pediatric patients: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Semin Dial, vol. 15, no. 6, pp. 427-9, 2002.
, “Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation.”, J Am Soc Nephrol, vol. 17, no. 6, pp. 1735-45, 2006.
, “Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.”, PLoS One, vol. 5, no. 9, p. e12873, 2010.
,